BIOVENTUS INC. Share-based Payment Arrangement, Expense
BIOVENTUS INC. (BVS) reported Share-based Payment Arrangement, Expense of $4.77 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-05
- BIOVENTUS INC. share-based payment arrangement, expense for the quarter ending 2026-06-27 was $4.77M, a 41.95% increase year-over-year.
- BIOVENTUS INC. share-based payment arrangement, expense for the quarter ending 2026-03-28 was $3.26M, a 35.21% increase year-over-year.
- BIOVENTUS INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $3.24M, a 31.27% decline year-over-year.
- BIOVENTUS INC. share-based payment arrangement, expense for the quarter ending 2025-09-27 was $3.18M, a 27.50% increase year-over-year.
- BIOVENTUS INC. share-based payment arrangement, expense for fiscal 2025 was $12.19M, a 4.96% decline from fiscal 2024.
- BIOVENTUS INC. share-based payment arrangement, expense for fiscal 2024 was $12.83M, a 441.31% increase from fiscal 2023.
- BIOVENTUS INC. share-based payment arrangement, expense for fiscal 2023 was $2.37M, a 86.15% decline from fiscal 2022.
- BIOVENTUS INC. share-based payment arrangement, expense for fiscal 2022 was $17.11M, a 12.25% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-27 | $4.77M 10-Q · filed 2026-08-05 | $8.04M 10-Q · filed 2026-08-05 | $11.28M derived: sum of 3 quarters · filed 2026-08-05 | $14.45M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-28 | $3.26M 10-Q · filed 2026-05-06 | $6.51M derived: sum of 2 quarters · filed 2026-05-06 | $9.68M derived: sum of 3 quarters · filed 2026-05-06 | $13.04M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2025-12-31 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $6.42M derived: sum of 2 quarters · filed 2026-03-05 | $9.78M derived: sum of 3 quarters · filed 2026-03-05 | $12.19M 10-K · filed 2026-03-05 | ||
| 2025-09-27 | $3.18M 10-Q · filed 2025-11-04 | $6.54M derived: sum of 2 quarters · filed 2025-11-04 | $8.95M 10-Q · filed 2025-11-04 | $13.67M derived: sum of 4 quarters · filed 2026-03-05 | ||
| 2025-06-28 | $3.36M 10-Q · filed 2025-08-06 | $5.78M 10-Q · filed 2025-08-06 | $10.49M derived: sum of 3 quarters · filed 2026-03-05 | $12.98M derived: sum of 4 quarters · filed 2026-03-05 | ||
| 2025-03-29 | $2.41M 10-Q · filed 2025-05-06 | $7.13M derived: sum of 2 quarters · filed 2026-03-05 | $9.62M derived: sum of 3 quarters · filed 2026-03-05 | $15.18M derived: sum of 4 quarters · filed 2026-03-05 | ||
| 2024-12-31 | $4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $7.21M derived: sum of 2 quarters · filed 2026-03-05 | $12.77M derived: sum of 3 quarters · filed 2026-03-05 | $12.83M 10-K · filed 2026-03-05 | $9.61M 10-K · filed 2025-03-11 | |
| 2024-09-28 | $2.49M 10-Q · filed 2025-11-04 | $2.06M 10-Q · filed 2024-11-05 | $8.05M derived: sum of 2 quarters · filed 2025-11-04 | $8.11M 10-Q · filed 2024-11-05 | ||
| 2024-06-29 | $5.56M 10-Q · filed 2025-08-06 | $3.46M 10-Q · filed 2024-08-06 | $6.05M 10-Q · filed 2024-08-06 | |||
| 2024-03-30 | $2.59M 10-Q · filed 2024-05-07 | |||||
| 2023-12-31 | $2.37M 10-K · filed 2026-03-05 | |||||
| 2022-12-31 | $17.11M 10-K · filed 2025-03-11 | |||||
| 2021-12-31 | $19.50M 10-K · filed 2024-03-12 |